Payers restricting the use of specialty drugs in their drug formularies makes good economic sense when you look at their bottom line, but how much do we know about this process of deciding which drugs make the cut? The fact is, we know very little about how a payer decides to give one specialty medicine preference over another, and the prescription you end up taking, may not be the one your doctor wanted for you. Read more here. (Source: Robert Galvin, Roger Longman, Harvard Business Review, 11/4/14).
You are here: / / Has The Time Come To Demand Transparency In Drug Formulary Decisions?